Tafmune EM Tablet

Tafmune EM Tablet contains emtricitabine and tenofovir disoproxil fumarate. It is made by a certified pharmaceutical producer. This tablet is widely stocked by resellers and bulk suppliers serving HIV treatment markets.

What This Product Treats

Tafmune EM Tablet is used in combination antiretroviral therapy for HIV infection. The medication is part of multi-drug regimens designed to suppress viral replication. It maintains immune function. Stockists source this product for clinics, dispensaries, and treatment programs needing nucleoside reverse transcriptase inhibitor components.

How It Works

The two active compounds work through the same mechanism class. Emtricitabine and tenofovir disoproxil fumarate are both nucleoside reverse transcriptase inhibitors. They block the reverse transcriptase enzyme that HIV uses to convert its genetic material into host cell DNA.

When the enzyme cannot function, the virus cannot replicate effectively. This action reduces viral load in the blood. It allows the immune system to recover function over time. Both components are absorbed through the digestive system. They accumulate in lymphoid tissues where HIV concentrates most heavily.

Available Strengths and Pack Sizes

Tafmune EM Tablet 200/300 mg (emtricitabine 200 mg + tenofovir disoproxil fumarate 300 mg)

• 30-tablet blister packs
• 60-tablet blister packs
• 90-tablet bottle packs

Side Effect

Common effects include nausea, diarrhea, headache, and fatigue. These are typically most noticeable in the first weeks of therapy. Some patients report dizziness or abdominal discomfort.

Kidney function changes and bone density reduction are documented with tenofovir regimens. These warrant monitoring over extended use. Lactic acidosis is a rare but serious potential effect. It requires immediate medical attention if severe fatigue, difficulty breathing, or unexplained muscle pain develop.

Side effect incidence remains consistent across batches and manufacturing standards.

Storage, Shelf Life, and Packaging

Tafmune EM Tablet has a shelf life of 24 months from manufacture. Store tablets between 15 and 30 degrees Celsius in a dry environment. Keep relative humidity below 60 percent. Protect from direct sunlight and moisture. Blister packs should remain sealed until dispensing.

Wholesale buyers should verify manufacturing dates upon receipt. Rotate stock using first-in, first-out principle. Bulk cartons ship in protective secondary packaging to maintain integrity during transit.

Pricing and Availability

GetHIVTreatment offers Tafmune EM Tablet 200/300 mg at $2.40 per tablet for bulk carton orders. Per-strip pricing and case discounts are available for high-volume resellers and treatment program suppliers.

Why Buyers Choose This Product

Resellers choose Tafmune EM Tablet for consistent quality and reliable supply. The manufacturer maintains certification across major regulatory frameworks. This ensures compatibility with international procurement standards. The product moves steadily through wholesale channels. It is a dependable inventory item for facilities requiring continuous antiretroviral stock.